Ultrapar (UGPA3) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Jul, 2026Executive summary
Recurring EBITDA reached R$1.28 billion in Q2 2024, up 37% year-over-year, mainly driven by Ipiranga's performance and margin normalization.
Net income for Q2 2024 was R$491 million, a 106% increase year-over-year, supported by EBITDA growth and lower net financial expenses.
Net revenue for H1 2024 reached R$62.74 billion, up from R$60.14 billion year-over-year, with gross profit rising to R$4.17 billion.
Interim dividends of R$276 million were approved for H1 2024.
Cash flow from operations in Q2 2024 was R$1.3 billion, up 44% year-over-year.
Financial highlights
Accumulated EBITDA for 2024 stands at R$2.588 billion, 32% higher year-over-year.
Investments totaled R$479 million in Q2 2024, up 24% year-over-year, mainly due to Ultracargo.
Net debt at the end of Q2 2024 was R$7.7 billion, down from March 2024, with leverage at 1.2x net debt/EBITDA.
Earnings per share (basic) for H1 2024 was R$0.7895, up from R$0.4346 in H1 2023.
Cash and cash equivalents at June 30, 2024, stood at R$3.83 billion.
Capital allocation and financing
Net debt figures do not yet include R$222 million from the Extrafarma sale, received in August.
Acquisition of a significant stake in Hidrovias for R$1.3 billion, now classified as an investment.
R$1.8 billion in investments and acquisitions in Q2 2024.
Ultragaz issued R$700 million in debentures in July 2024.
Dividend distribution of R$276 million for H1 2024.
Latest events from Ultrapar
- Record EBITDA and cash flow in 2025, with stable leverage and strong segment results.UGPA3
Q4 20258 Jul 2026 - Net revenue rose 10% to R$36.8 billion, Adjusted EBITDA up 96%, and net income reached R$914 million.UGPA3
Q1 20267 Jul 2026 - Revenue up 10% year-over-year, but EBITDA and net income declined due to logistics and sector challenges.UGPA3
Q1 20256 Jul 2026 - Net income surged 134% to R$1.2 billion, with strong cash flow and major share buyback.UGPA3
Q2 20256 Jul 2026 - EBITDA and net income grew, leverage fell to 1.7x, and strategic moves boosted results.UGPA3
Q3 20256 Jul 2026 - Net revenue rose 6% to R$133.5 billion, with stable net income and strong investment activity.UGPA3
Q4 20242 Jul 2026 - Recurring EBITDA declined 24% year-over-year, with net income and debt reflecting mixed trends.UGPA3
Q3 20242 Jul 2026 - Disciplined growth, operational excellence, and regulatory gains drive robust, resilient results.UGPA3
Investor Day 20251 Jul 2026 - Disciplined capital allocation and sector leadership drive strong growth and sustainable returns.UGPA3
Investor presentation26 May 2026